Loading…
Cosmos Health Inc. is projected to rise to $0.2679 by 2027, a +1% move from its current price of $0.2651. COSM is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $0.2556 | $0.2653 | $0.2753 | +0.06% |
| May 30 | $0.2518 | $0.2654 | $0.2798 | +0.13% |
| May 31 | $0.249 | $0.2656 | $0.2833 | +0.19% |
| Jun 1 | $0.2467 | $0.2658 | $0.2863 | +0.25% |
| Jun 2 | $0.2447 | $0.2659 | $0.289 | +0.31% |
| Jun 3 | $0.2429 | $0.2661 | $0.2915 | +0.38% |
| Jun 4 | $0.2413 | $0.2663 | $0.2938 | +0.44% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.2413 | $0.2663 | $0.2938 | +0.44% |
| Week 2 | $0.2327 | $0.2674 | $0.3073 | +0.88% |
| Week 3 | $0.2265 | $0.2686 | $0.3185 | +1.33% |
| Week 4 | $0.2216 | $0.2698 | $0.3284 | +1.77% |
| Week 5 | $0.2175 | $0.271 | $0.3376 | +2.22% |
| Week 6 | $0.2139 | $0.2722 | $0.3463 | +2.67% |
| Week 7 | $0.2107 | $0.2734 | $0.3546 | +3.12% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, the United Arab Emirates, Albania, North Macedonia, and Cyprus. The company provides prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names.
It offers ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvastatin), Miltus (Donepezil), Newzypra (Olanzapine), PNEUMO-KAST (Montelukast), Sahar (Pioglitazone), VIVALCID (Leucovorin), and Diabit-is (Sitagliptin). In addition, the company offers branded biocides and antiseptic soaps under the C-Sept and C-Scrub brand names; and other pharmaceutical products include Melatonin Spray, used to reduce insomnia and jet lag; Otikon ear drops, which is a Class II medical device in the form of ear drops; and baby foods, such as organic powder milk, pasta with minced meat, whole grain rice cereals, whole grain cereal porridges, and organic rice creams with vanilla milk, as well as pear, carrot and banana purée under the Bio-bebe brand. It serves wholesalers and retail healthcare providers.
The company was founded in 2009 and is headquartered in Thessaloniki, Greece.
Cosmos Health Inc. (COSM) is a healthcare company with a current price of $0.2525 and a market cap of $13.21M. It ranks 5075 in market capitalization. The stock trades in a broad, low-price space and presents a near-term outlook that is mixed based on the latest technical indicators.
The thirty-day range runs from $0.1959 to $0.3255, highlighting potential volatility in the near term. Support is noted at $0.253 and resistance at $0.406, framing a narrow trading band around the current level. The SMA(50) sits at $0.333 and the SMA(200) at $0.593, suggesting the price is presently below both major moving averages.
A major floor 41.5% below — a decisive break under it would weaken the trend.
The nearest floor, 4.6% below — buyers have tended to step in here.
The nearest ceiling, 53.1% above — a clean break opens room to run.
A major ceiling 98.0% above — clearing it would confirm fresh momentum.
Key COSM support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of COSM market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.264 | Buy | $0.2673 | Sell |
| MA 10 | $0.2808 | Sell | $0.2808 | Sell |
| MA 20 | $0.3136 | Sell | $0.3018 | Sell |
| MA 50 | $0.3294 | Sell | $0.3358 | Sell |
| MA 100 | $0.3842 | Sell | $0.3965 | Sell |
| MA 200 | $0.5864 | Sell | $0.4896 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 32.38 | Neutral |
| Stoch RSI (14) | 27.55 | Neutral |
| CCI (20) | -94.89 | Neutral |
| Williams %R (14) | -87.63 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -20.18 | Sell |
| Bollinger %B (20,2) | 0.19 | Neutral |
| Stochastic %K (14) | 12.37 | Buy |
| TRIX (15) | -0.72 | Sell |
| Awesome (5,34) | -0.07 | Sell |
| Ultimate (7,14,28) | 19.62 | Buy |
| Momentum (10) | -0.04 | Sell |
| Aroon Osc (25) | -60.00 | Sell |
| Hull MA (9) | 0.25 | Buy |
| ADX (14) | 25.42 | Sell |
| ATR (14) | 0.01 | Info |
The 30-day technical picture is neutral. RSI(14) is 30, indicating an oversold-like condition but not extreme. The price is trading below both key moving averages, with SMA50 at $0.333 and SMA200 at $0.593, which can keep downside pressure limited to the near term but may hinder a strong breakout.
The stock’s near-term range spans from $0.1959 to $0.3255, with support at $0.253 and resistance at $0.406, outlining a cautious path in the coming weeks.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.253 | $0.2651 | $0.3447 | 0% | Neutral | |
| $0.205 | $0.2679 | $0.3749 | +1% | Neutral | |
| $0.1818 | $0.2469 | $0.3618 | -7% | Neutral | |
| $0.1744 | $0.2446 | $0.3717 | -8% | Neutral | |
| $0.1664 | $0.2403 | $0.3763 | -9% | Neutral | |
| $0.193 | $0.2864 | $0.4605 | +8% | Neutral | |
| $0.2265 | $0.3447 | $0.5675 | +30% | Bullish | |
| $0.2198 | $0.3426 | $0.5762 | +29% | Bullish | |
| $0.2132 | $0.3401 | $0.5834 | +28% | Bullish | |
| $0.2027 | $0.3306 | $0.5774 | +25% | Bullish | |
| $0.2793 | $0.5048 | $0.951 | +90% | Bullish | |
| $0.3119 | $0.6795 | $1.43 | +156% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.253 | $0.2651 | $0.3149 | +0.00% |
| June 2026 | $0.2382 | $0.282 | $0.3433 | +6.37% |
| July 2026 | $0.2344 | $0.2807 | $0.348 | -0.45% |
| August 2026 | $0.2268 | $0.274 | $0.3444 | -2.38% |
| September 2026 | $0.2296 | $0.2795 | $0.3553 | +2.00% |
| October 2026 | $0.2285 | $0.2802 | $0.3598 | +0.24% |
| November 2026 | $0.2168 | $0.2674 | $0.3464 | -4.57% |
| December 2026 | $0.2127 | $0.2639 | $0.3447 | -1.31% |
Click any year to see its month-by-month COSM forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, COSM could reach as high as $0.3447, with a base case around $0.2651 and support toward $0.253 — roughly 0% from $0.2651. A consolidation phase looks the most probable path here.
Expect COSM to range from $0.205 to $0.3749 through 2027. The $0.2679 average target implies a +1% move from current prices. That is up +1% on the projected 2026 average. Price action looks broadly range-bound.
The COSM price prediction for 2028 points to an average of $0.2469 (low $0.1818, high $0.3618) — a potential decline of -7% on today's $0.2651. A consolidation phase looks the most probable path here.
In 2029, COSM is projected to trade between $0.1744 and $0.3717, averaging $0.2446 — a potential decline of -8% from today's $0.2651. That is -1% versus the projected 2028 average. Price action looks broadly range-bound.
Cosmos Health Inc.'s 2030 outlook centres on $0.2403, within a $0.1664 to $0.3763 range. That is -2% versus the projected 2029 average. That marks a -9% change versus current levels. A consolidation phase looks the most probable path here.
By 2031, COSM could reach as high as $0.4605, with a base case around $0.2864 and support toward $0.193 — roughly +8% from $0.2651. Price action looks broadly range-bound.
Expect COSM to range from $0.2265 to $0.5675 through 2032. The $0.3447 average target implies a +30% move from current prices. That is up +20% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The COSM price prediction for 2033 points to an average of $0.3426 (low $0.2198, high $0.5762) — a potential gain of +29% on today's $0.2651. Momentum favours further upside here.
In 2034, COSM is projected to trade between $0.2132 and $0.5834, averaging $0.3401 — a potential gain of +28% from today's $0.2651. That is -1% versus the projected 2033 average. Buyers look set to stay in control over this stretch.
Cosmos Health Inc.'s 2035 outlook centres on $0.3306, within a $0.2027 to $0.5774 range. That is -3% versus the projected 2034 average. That marks a +25% change versus current levels. Momentum favours further upside here.
By 2040, COSM could reach as high as $0.951, with a base case around $0.5048 and support toward $0.2793 — roughly +90% from $0.2651. Buyers look set to stay in control over this stretch.
Expect COSM to range from $0.3119 to $1.43 through 2050. The $0.6795 average target implies a +156% move from current prices. That is up +35% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in COSM today (≈ 3,772.161449 COSM) could be worth
$2,563.23
+$1,563.23 (+156%) by 2050 · US Dollar
Based on the average projected COSM price of $0.68 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in COSMwould be worth at today's price.
$1,000 invested in COSM on May 27, 2025 (≈ 2,150.537618 COSM) would be worth
$570.11
-$429.89 (-43.0%) today · 0.57× · US Dollar
Based on a COSM entry price of $0.465 vs. today's $0.2651.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.284 | $933.45 | -6.7% |
| 1 month ago | $0.363 | $730.3 | -27.0% |
| 3 months ago | $0.39 | $679.74 | -32.0% |
| 6 months ago | $0.642 | $412.93 | -58.7% |
| 1 year ago | $0.465 | $570.11 | -43.0% |
| All time (5.0y) ago | $4.88 | $54.32 | -94.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our COSM forecast.
Our base-case forecast reaches $0.53 around 2050.
Implied market cap at $0.53: $28.85M
The multi-year forecast shows a gradual shift from neutral in the near term to more bullish momentum later in the horizon. For 2030, the avg is $0.233 with a max of $0.3686 and a min of $0.1598, delivering an ROI of -7.7% in a neutral outlook. The forecast turns bullish in the early-to-mid 2030s, with 2032 avg $0.3406 and ROI 34.9%, 2033 avg $0.3337 and ROI 32.1%, 2034 avg $0.3291 and ROI 30.3%, and 2035 avg $0.3256 and ROI 28.9%.
The longer-horizon view strengthens, with 2040 avg $0.4968 and ROI 96.8%, and 2050 avg $0.6749 and ROI 167.3%, while the 2050 max is $1.44. Sentiment shifts to bullish in 2032–2035 and remains bullish through 2040 and 2050. These figures are estimates and not guarantees; actual results can vary with market conditions.
Tap a question to reveal the answer.
The forecast shows an avg price of $0.233 with a min of $0.1598 and a max of $0.3686; ROI is -7.7% and sentiment is NEUTRAL.
Yes. The 2050 forecast lists a max of $1.44, with an avg of $0.6749 and ROI of 167.3%; sentiment is BULLISH.
Current price is $0.2525 and market cap is $13.21M; the stock ranks 5075.
For 2040 the avg is $0.4968 with a max of $0.9491 and a min of $0.2691; ROI is 96.8% and sentiment is BULLISH.
The 2027 forecast shows an avg of $0.2571, a min of $0.1956 and a max of $0.3622; ROI is 1.8% and sentiment is NEUTRAL.
Cosmos Health Inc. Community Discussion
0Share your Cosmos Health Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.